Kevin Michael Krause, Chief Strategy Officer: AN2 Therapeutics ANTX Sell · Filed 24/01/11

Trade details

Type: Insider sale
Amount: $149,378.38
Shares · price: 7,417 sh · $20.14 a share
Held after: 1,914 sh
Stock: AN2 Therapeutics ANTX
Person: Kevin Michael KrauseChief Strategy Officer
Trade date: 24/01/09
Filed: 24/01/11
Days to filing: 2 days

Sold 79.5% of holdings

Share of holding sold: 79.5%

AN2 Therapeutics trades, last 26 weeks

What else happened in AN2 Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/10~24/02/08

Kevin Michael Krause's recent trades

Kevin Michael KrauseChief Strategy Officer
Sell10b5-1 planAN2 Therapeutics
Sell10b5-1 plan
AN2 Therapeutics
ANTX
$52K
2,583 sh
$52K
Filed 24/01/04
Traded 24/01/02